At­se­na gets Bain's sup­port in $150M Se­ries C to thwart blind­ness with gene ther­a­py

There’s still mon­ey to be raised by gene ther­a­py star­tups with good clin­i­cal da­ta.

On Wednes­day, North Car­oli­na biotech At­se­na Ther­a­peu­tics said it had raised …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER